AGEN

5.9702.77%
TL

Thomas L. Harrison

Lead Independent Director

Dr. Thomas L. Harrison, LHD, also known as Tom, is Strategic Advisor of Isosceles Pharmaceuticals, Inc. He is Director of MainStem, Inc. He is Director of Magellan Jets, LLC. Dr. Harrison is Independent Director of Agenus Inc. from August 7, 2024. He has been a Board Director at ACTV8, INC. since October 2021. He serves as an Independent Director at Acurx Pharmaceuticals, Inc. since July 2021. He has served as Chairman Emeritus of the DAS Holdings Inc. (formerly known as Diversified Agency Services) ('DAS') division of Omnicom Group Inc. since June 2016, having previously served as its President, then Chairman and CEO. DAS provides an unparalleled range of marketing communications services including public relations, crisis management, branding, sales promotion, customer relationship management and specialty communications including health care advertising. He is multi-faceted career brought him to Omnicom in 1992 when Omnicom acquired firm he co-founded, Harrison & Star Business Group in October 1987, which was the most successful and rapidly growing agency group in the healthcare industry. Dr. Harrison served as Chairman of the Harrison & Star Group and Chairman of Diversified Healthcare Communications, a group of eight healthcare agencies within Omnicom, until his appointment as President of DAS in April 1997. He was named Chairman and Chief Executive of DAS in 1998 and remained in this role until being named Chairman Emeritus in 2013. With an advanced degree in cell biology and physiology, he began his business career at Pfizer Laboratories as a pharmaceutical sales Representative His agency, Harrison & Star, was an entrepreneurial agency that fused high science with high creativity. The agency became uniquely positioned in the market due to its understanding of the clinical and scientific underpinnings of prescription product promotion and its ability to communicate with practicing physicians using the language of science not sales. He brought his scientific acumen and career experience in healthcare, wellness, branding and communication to the evolving cannabis marketplace in 2015 when he joined the Board of Directors of Zynerba Pharmaceuticals, a leader in pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare psychiatric disorders. He joined Merida Capital Partners in 2019 as Senior Operating Partner. At Merida, he serves as a strategic and operational advisor across the firm's portfolio companies. Dr. Harrison is focused on contributing his expertise to this dynamic industry as it continues to unfold. He sits on the Board of Fifth Street Asset Management since 2014 where he serves as Lead Independent Director. He also served on the Board of Madison Logic, a digital business to business agency since 2017. He serves as Director of MainStem, Inc. since 2022, a cannabis-related supply company and also ACTV8me since 2019, a digital advertising attribution company. He is a past Board Member at ePocrates, a publicly traded healthcare information company, where he served from 2006 until its acquisition in 2013 and he has also served as a Board Member for The Morgans Hotel Group from 2006 to 2013. He joined the Board of Dipexium Pharmaceuticals in 2011 and served until its acquisition in 2017. He was a Board Member of rVue, a digital out-of-home media company from 2013 until 2016 and sat on the Board of Social Growth Technologies from 2014 until its acquisition in 2016. He was appointed to the Board of Directors of Zynerba Pharmaceuticals in 2015. He serves as Director at Sampark Public Relations Pvt. Ltd., rVue Holdings, Inc., GL Brands, Inc. and Delano Hotel, Inc. He serves as Member of Board of Advisors at Campus Venture Network, Inc. He serves as Trustee at Montefiore Health System. He serves as Member of the Board of Directors at orldmedicalleaders.com. He serves as Lead Independent Director at Advanced Flower Capital Inc. (formerly known as AFC Gamma, Inc.) since July 2020. He earned an LH.D and Masters of Science in cell biology from West Virginia University and a Bachelor of Science in cell biology and physiology from Shepherdstown University.

Positions